86 related articles for article (PubMed ID: 309344)
1. [Pharmacology of several aromatic amino acid decarboxylase inhibitors].
Uspenskiĭ AE; Dabagov NS; Skoldinov AP
Biull Eksp Biol Med; 1978 Oct; 86(10):444-7. PubMed ID: 309344
[TBL] [Abstract][Full Text] [Related]
2. [The pharmacology of 3,4-dihydroxyphenyl-alpha-hydroxypropionic acid sodium salt].
Uspenskiĭ AE
Farmakol Toksikol; 1978; 41(4):418-20. PubMed ID: 566675
[TBL] [Abstract][Full Text] [Related]
3. [Facilitation of the effects of L-DOPA by alpha-methyldopa].
Uspenskiĭ AE; Korobov NV
Biull Eksp Biol Med; 1976 Mar; 81(3):314-6. PubMed ID: 986203
[TBL] [Abstract][Full Text] [Related]
4. The effect of L-DOPA on brain polysomes and protein synthesis: probable mediation by intracellular dopamine.
Weiss BF; Roel LE; Munro HN; Wurtman RJ
Adv Neurol; 1974; 5():87-99. PubMed ID: 4155238
[No Abstract] [Full Text] [Related]
5. Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
Watanabe AM; Parks LC; Kopin IJ
J Clin Invest; 1971 Jun; 50(6):1322-8. PubMed ID: 5578236
[TBL] [Abstract][Full Text] [Related]
6. [ACTION OF CERTAIN L-DOPA/5-HTP DECARBOXYLASE INHIBITORS ON HYPOTHALAMO-HYPOPHYIAL NEUROSECRETION IN THE RAT].
SOULAIRAC A; SOULAIRAC ML
C R Seances Soc Biol Fil; 1964; 158():1445-7. PubMed ID: 14250544
[No Abstract] [Full Text] [Related]
7. Reduction of aromatic L-amino acid decarboxylase protein in rats after chronic administration of alpha-methyldopa.
Culvenor AJ; Jarrott B
Mol Pharmacol; 1979 Jan; 15(1):86-98. PubMed ID: 106235
[No Abstract] [Full Text] [Related]
8. Aromatic amino acid decarboxylase inhibitors.
Porter CC
Fed Proc; 1971; 30(3):871-6. PubMed ID: 5575298
[No Abstract] [Full Text] [Related]
9. Antagonistic actions of renal dopamine and 5-hydroxytryptamine: effects of amine precursors on the cell inward transfer and decarboxylation.
Soares-da-Silva P; Pinto-do-O PC
Br J Pharmacol; 1996 Mar; 117(6):1187-92. PubMed ID: 8882614
[TBL] [Abstract][Full Text] [Related]
10. Reaction of dopa decarboxylase with L-aromatic amino acids under aerobic and anaerobic conditions.
Bertoldi M; Borri Voltattorni C
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):533-8. PubMed ID: 11085948
[TBL] [Abstract][Full Text] [Related]
11. [A search of new inhibitors of 5-hydroxytryptophane decarboxylase (5-HTP-D)].
Robak J
Folia Med Cracov; 1969; 11(1):125-55. PubMed ID: 5802128
[No Abstract] [Full Text] [Related]
12. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
Biggs CS; Fisher A; Starr MS
Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134
[TBL] [Abstract][Full Text] [Related]
13. [Research on the inhibitory action of several salicylic chalcones on the aromatic L-aminoacid-decarboxylase].
Lesieur-Demarquilly I; Mizon J; Osteux R
Ann Pharm Fr; 1973 Nov; 31(11):705-8. PubMed ID: 4794659
[No Abstract] [Full Text] [Related]
14. Aromatic L-amino acid decarboxylase: conformational change in the flexible region around Arg334 is required during the transaldimination process.
Ishii S; Hayashi H; Okamoto A; Kagamiyama H
Protein Sci; 1998 Aug; 7(8):1802-10. PubMed ID: 10082378
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent depressor effect of L-dopa in dogs with inhibition of extracerebral dopa decarboxylase.
Wilke WL
Pediatr Res; 1983 Nov; 17(11):924-5. PubMed ID: 6359046
[TBL] [Abstract][Full Text] [Related]
16. Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats.
Buck K; Ferger B
Neurobiol Dis; 2008 Feb; 29(2):210-20. PubMed ID: 17920284
[TBL] [Abstract][Full Text] [Related]
17. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
Biggs CS; Starr MS
Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of dopa decarboxylation by RO4-4602, MK 485 and MK 486 in human liver homogenates.
Vogel WH; Mahoney K; Hare TA
Arch Int Pharmacodyn Ther; 1972; 198(1):85-93. PubMed ID: 4538242
[No Abstract] [Full Text] [Related]
19. Structural insight into Parkinson's disease treatment from drug-inhibited DOPA decarboxylase.
Burkhard P; Dominici P; Borri-Voltattorni C; Jansonius JN; Malashkevich VN
Nat Struct Biol; 2001 Nov; 8(11):963-7. PubMed ID: 11685243
[TBL] [Abstract][Full Text] [Related]
20. 3-O-methyldopa blocks dopa metabolism in rat corpus striatum.
Reches A; Fahn S
Ann Neurol; 1982 Sep; 12(3):267-71. PubMed ID: 7137962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
